18F-MNI-952

N/A

Report date: 2025/11/24 17:58:27

Base Information

Drug Name18F-MNI-952

Drug Alias Name18F-UCB-K18F-MNI-952[18F]UCB-K

ClassificationRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionMicrotubule-associated protein tau modulators

TargetsMicrotubule-associated protein tau

Therapy Area/IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesInvicro Llc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesMolecular Neuroimaging Llc

Active IndicationsN/A

Inactive IndicationsAlzheimer DiseaseSupranuclear Palsy, Progressive

Other Information

ATC CodeN/A